Home › Funds › Atle Fund Management AB › MANE
Atle Fund Management AB position in MANE
Veradermics, Incorporated · Health Care
Atle Fund Management AB reported holding 10,106 shares of MANE (Veradermics, Incorporated) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.33% of its reported portfolio and ranking #39 among its reported holdings. Atle Fund Management AB first reported this position in Q3 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Atle Fund Management AB's MANE position evolved
Atle Fund Management AB first disclosed a stake in MANE in Q3 2026 at 10,106 shares (US$1.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 10.11K | $1.23M | New |
About MANE and 13F data
MANE (Veradermics, Incorporated) is a Health Care company. 185 other funds we track also report a position in MANE — the largest reported positions include MONTANOVA CAPITAL, LLC (US$512.5M), SR ONE CAPITAL MANAGEMENT, LP (US$295.3M), Deep Track Capital, LP (US$245.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MANE
- MONTANOVA CAPITAL, LLC 4.17M sh · $512.53M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.40M sh · $295.29M · Q2 2026
- Deep Track Capital, LP 2.00M sh · $245.88M · Q2 2026
- Siren, L.L.C. 1.32M sh · $160.54M · Q3 2026
- Maverick Capital 789.98K sh · $97.12M · Q2 2026
- MAVERICK CAPITAL LTD 789.98K sh · $97.12M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 731.15K sh · $89.89M · Q2 2026
- EMERALD ADVISERS, LLC 288.37K sh · $35.45M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 209.92K sh · $25.81M · Q2 2026
- Logos Global Management LP 180.00K sh · $22.13M · Q2 2026
- Sofinnova Investments, Inc. 148.99K sh · $18.32M · Q2 2026
- Kalehua Capital Management LLC 145.69K sh · $17.91M · Q2 2026
More on Atle Fund Management AB
FAQ
How long has Atle Fund Management AB held MANE?
Atle Fund Management AB has disclosed MANE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Atle Fund Management AB's current position in MANE?
As of Q3 2026, Atle Fund Management AB holds 10.11K shares of MANE (Veradermics, Incorporated), valued at $1.23M, representing 0.33% of its reported portfolio and ranking #39.
Has Atle Fund Management AB been buying or selling MANE?
In the latest 13F filing (Q3 2026), Atle Fund Management AB newly opened its position in MANE.
Which other funds hold MANE?
Other major institutional holders of MANE include MONTANOVA CAPITAL, LLC, SR ONE CAPITAL MANAGEMENT, LP, Deep Track Capital, LP, among 185 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.